THELIATINIB

SynDRA canonical compound SYN0040611 — structure-anchored drug synonym record

Clinical phase	Phase 1
Primary target(s)	EGFR \| ERBB4
Mechanism of action	egfr inhibitor
Indication	esophageal cancer
Disease area	oncology

All known targets

EGFR
ERBB4
LCK
LYN
TNK1
YES1

Mechanisms of action (all sources)

EGFR INHIBITOR
Epidermal growth factor receptor erbB1 inhibitor
ERBB4 INHIBITOR
LCK INHIBITOR
LYN INHIBITOR
TNK1 INHIBITOR
YES1 INHIBITOR

Cross-references

PubChem CID: 54759275
ChEMBL: CHEMBL5314410
DrugBank: DB21453
TTD: D0J3EA

Synonyms

Xiliertinib
HMPL-309
Second EGFR tyrosine kinase inhibitor (cancer), Hutchison Medipharma
xiliertinib
6ZZ3B7NZ0B
UNII-6ZZ3B7NZ0B
XILIERTINIB [INN]
XILIERTINIB [WHO-DD]
RefChem:189162
HMPL309
Theliatinib (HMPL-309)
SCHEMBL247509
orb1299921
SCHEMBL29370993
EX-A3179
s8584
ZB1620
AKOS032946520
AC-35865
MS-27965
HY-104066
CS-0027986
T7322
G16819

Look up THELIATINIB in the interactive SynDRA portal →